Ignite Creation Date:
2024-05-05 @ 6:31 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00499863
Status:
COMPLETED
Last Update Posted:
2017-04-26
First Post:
2007-07-10
Brief Title:
Evaluate the Efficacy Safety of Methylphenidate Transdermal System MTS in Adolescents Aged 13-17 Years With ADHD
Sponsor:
Noven Therapeutics
Organization:
Noven Therapeutics
Study Overview
Official Title:
A Phase IIIb Randomized Double-Blind Multi-Center Parallel-Group Placebo-Controlled Dose Optimization Study Designed to Evaluate the Efficacy and Safety of MTS in Adolescents Aged 13-17 Years With ADHD
Status:
COMPLETED
Status Verified Date:
2017-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To assess the efficacy and safety of efficacy of MTS compared to placebo
Detailed Description:
To assess the efficacy and safety of efficacy of MTS compared to placebo as determined by the change in the clinician completed ADHD Rating Scale - Version 4th Edition ADHD-RS-IV in the symptomatic treatment of adolescents aged 13-17 years diagnosed with ADHD
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None